R-Three Technologies Expands Advisory Board -- 2 Health and Wellness Doctors Join Team
R-Three Technologies, Inc. (OTC Symbol RRRT) announced the appointment of Dr. Hamid Alizadeh and Dr. David M. Snipper to its Advisory Board, enhancing its health and wellness initiatives. Dr. Alizadeh, a former ER specialist turned wealth manager with $50M assets under management, aims to leverage his expertise in wellness for product development. Dr. Snipper, an anesthesiologist with a background in holistic healing, brings valuable insights to the company's healthcare approach. CEO Stan Kolaric expressed optimism about the collaborative potential of the growing team.
- Strengthening of advisory board with experienced professionals.
- Dr. Alizadeh has a significant background in wellness, potentially enhancing product offerings.
- Dr. Snipper's expertise in holistic treatments may diversify R3T's health-focused initiatives.
- None.
Los Angeles, Dec. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- R-Three Technologies, Inc. (OTC Symbol RRRT): R3T is pleased to announce that Dr. Hamid Alizadeh and Dr. David M. Snipper agreed to join the R3T Advisory Board. The addition of the doctors to the advisory board strengthens the company’s health and wellness offerings.
Dr. Alizadeh was an ER specialist and MD for 10 years before he gave up his practice to move into the world of finance. As an ER specialist, he treated patients from all walks of life. When he treated his patients he not only wanted to get rid of their current malady but wanted to look and see what else he could do to prolong their lives. This was the genesis of his interest in overall wellness. When he retired from medicine to pursue a career in finance many thought that was a risky move. His background in medicine coupled with his bedside manner allowed him to quickly attract clients so that he could create healthy long-term portfolios indexed to market and married with an insurance wrapper. As a wealth manager, he now manages over 1000 clients and has trained and supervised a number of referring agents. He currently has
“The people on this team are top-notch,” said Dr. Hamid Alizadeh. “Having a chance to interact with both Keith Hasting a former VP of Wells Fargo who shares my background and Peter Van Brunt J.D. showed me how in synch we are as a team. The two board additions of Bruce and David Langer are major wins for us. There is no reason why we can’t become a powerhouse in the wellness industry with this depth of talent. My vision for future offerings is a healthy drink that prolongs life and is not filled with sugar and caffeine like most drinks. I look forward to contributing where I can.”
Dr. David M. Snipper started his career as an anesthesiologist who graduated from the University of San Diego School of Medicine and completed his residency at UC Irvine Medical Center. He remained on staff in a teaching position as Assistant Clinical Professor and Director of the Pain Management Program. In that role, he also published several research articles relating to the multi-disciplinary approach to the treatment of complex pain disorders. He moved to Las Vegas to run a private practice of anesthesiology and ultimately became a partner at the largest group in Nevada. During his tenure, he served as medical director of several surgery centers. After a decade of practice, he became disenfranchised with the big pharm approach to healing and started studying herbal medicine and holistic healing. This path eventually led him to form a company called Global Green Sciences, whose mission statement was to advance healthcare by taking a new approach. New and old medicine would combine and then be practiced using compassion with respect to science and technology. He currently manages 2 clinics in Las Vegas.
“I have to thank Lance for bringing me on board to join this team of industrious individuals,” said Dr. David Snipper. “I am honored and ready to use my unique skill set to help in any way that I can to move our projects along. At my core, I am a healer that wants to find cures and not just treat symptoms. I am excited to be here because I believe R3T is a great platform for me to leverage the number of people that can be touched by my experience in the field.”
“The team is really coming together,” said Stan Kolaric, CEO of R3T. “These recent adds to our advisory board should help us round out our upcoming product offerings this year and develop our next generation of products. The true measure of a team is how they work in unison. When we work together it’s not like we can finish each other’s sentences but we all have different points of view that can all see the primary vision clearly. We have a couple more people to announce, but our roster is definitely looking up.”
Stan Kolaric
President CEO
Info@r3tinc.com
stankolaric@r3tinc.com
About R-Three Technologies Inc.
R Three Technologies is an early-stage development company with a success-driven Board which is focused on carefully pursuing several ventures it believes shows tremendous potential in development and manufacture of food and drink products. We are currently pursuing our options with a successful Juice Company within the beverage industry to formulate consumer products for large-scale distribution.
Forward-Looking Statements
This press release includes several forward-looking statements that reflect Management’s current views with respect to future events and financial performance. You can identify these statements by words such as “may”, “will”, “expect”, “anticipate”, “believe”, “estimate”, and “continue” or similar words. Those statements include statements regarding the intent, belief or current expectations of us and members of our management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forwarding look statements. Readers are urged to carefully review and consider the various disclosures made by us in this press release and our filings as posted on the OTC Markets with the Securities and Exchange Commission. Important factors currently known to Management could cause actual results to differ materially from those in forward-looking statements. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in reasonable data derived from and known about our business and operations.
FAQ
What is the significance of Dr. Alizadeh joining R3T's Advisory Board?
How can Dr. Snipper's experience impact R3T's offerings?
What are the future plans mentioned by the R3T team?